Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
7.27
-0.12 (-1.62%)
At close: Jan 30, 2026, 4:00 PM EST
7.25
-0.02 (-0.28%)
Pre-market: Feb 2, 2026, 8:49 AM EST

Aptevo Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
21.068.7116.922.6445.0439.98
Cash & Short-Term Investments
21.068.7116.922.6445.0439.98
Cash Growth
171.65%-48.45%-25.32%-49.75%12.67%221.17%
Accounts Receivable
---2.53.662.37
Receivables
---2.53.662.37
Prepaid Expenses
1.511.691.471.571.822.23
Restricted Cash
----1.262.56
Other Current Assets
0.080.260.690.740.780.13
Total Current Assets
22.6510.6619.0727.4552.5747.26
Property, Plant & Equipment
4.354.935.786.773.965.54
Other Long-Term Assets
----0.070.75
Total Assets
2715.5924.8434.2256.653.55
Accounts Payable
2.223.053.983.53.465.58
Accrued Expenses
1.91.862.12.112.082.76
Current Portion of Long-Term Debt
---211.675
Current Portion of Leases
0.80.77-0.42--
Current Unearned Revenue
----15.47-
Other Current Liabilities
0.690.531.140.682.091.2
Total Current Liabilities
5.616.217.228.7134.7614.54
Long-Term Debt
---1.463.7120.05
Long-Term Leases
3.994.635.46.081.342.36
Long-Term Unearned Revenue
----15.58-
Total Liabilities
9.610.8412.6216.2455.3936.95
Common Stock
0.110.080.060.050.050.05
Additional Paid-In Capital
286.5252.25235.61223.96215.23202.15
Retained Earnings
-269.22-247.58-223.45-206.04-214.06-185.61
Shareholders' Equity
17.394.7612.2217.971.2216.59
Total Liabilities & Equity
2715.5924.8434.2256.653.55
Total Debt
4.795.45.49.9616.7227.41
Net Cash (Debt)
16.273.3211.5112.6828.3312.57
Net Cash Growth
631.94%-71.18%-9.24%-55.24%125.46%-
Working Capital
17.044.4511.8418.7417.8132.73
Tangible Book Value
17.394.7612.2217.971.2216.59
Machinery
-12.2612.2612.2612.4311.73
Leasehold Improvements
-2.232.232.232.232.23
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q